Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-07 9:37 pm Purchase |
2025-03-27 | 13D | Dermata Therapeutics, Inc. DRMA |
PROEHL GERALD T | 804,098 13.300% |
804,098 (New Position) |
Filing History |
| 2025-04-03 6:00 pm Purchase |
2025-03-27 | 13D | Dermata Therapeutics, Inc. DRMA |
PROEHL GERALD T | 804,098 7.800% |
347 (+0.04%) |
Filing History |
| 2025-02-14 5:41 pm Purchase |
2024-12-31 | 13G | Dermata Therapeutics, Inc. DRMA |
Armistice Capital, LLC | 276,422 9.990% |
90,211 (+48.45%) |
Filing History |
| 2025-02-13 6:00 pm Unchanged |
2025-01-24 | 13D | Dermata Therapeutics, Inc. DRMA |
PROEHL GERALD T | 803,751 15.000% |
0 (Unchanged) |
Filing History |
| 2025-01-28 5:25 pm Purchase |
2025-01-23 | 13G | Dermata Therapeutics, Inc. DRMA |
Mitchell P. Kopin | 262,468 6.700% |
262,468 (New Position) |
Filing History |
| 2025-01-23 9:54 pm Purchase |
2025-01-21 | 13D | Dermata Therapeutics, Inc. DRMA |
PROEHL GERALD T | 803,751 16.000% |
788,247 (+5084.05%) |
Filing History |
| 2024-11-14 5:07 pm Purchase |
2024-09-30 | 13G | Dermata Therapeutics, Inc. DRMA |
Armistice Capital, LLC | 186,211 9.990% |
186,211 (New Position) |
Filing History |
| 2024-02-14 3:35 pm Purchase |
2023-12-31 | 13G | Dermata Therapeutics, Inc. DRMA |
Armistice Capital, LLC | 27,474 9.990% |
27,474 (New Position) |
Filing History |
| 2023-06-01 5:23 pm Purchase |
2023-05-23 | 13G | Dermata Therapeutics, Inc. DRMA |
Mitchell P. Kopin | 9,596 4.990% |
9,596 (New Position) |
Filing History |
| 2023-03-31 4:06 pm Purchase |
2023-03-20 | 13D | Dermata Therapeutics, Inc. DRMA |
HALE DAVID F | 2,989 1.900% |
2,989 (New Position) |
Filing History |
| 2023-03-30 4:06 pm Purchase |
2023-03-20 | 13D | Dermata Therapeutics, Inc. DRMA |
PROEHL GERALD T | 15,535 9.600% |
15,535 (New Position) |
Filing History |
| 2023-01-18 5:01 pm Purchase |
2022-08-12 | 13D | Dermata Therapeutics, Inc. DRMA |
PROEHL GERALD T | 15,504 28.900% |
261 (+1.71%) |
Filing History |
| 2022-05-05 5:00 pm Purchase |
2022-04-25 | 13D | Dermata Therapeutics, Inc. DRMA |
PROEHL GERALD T | 15,244 37.700% |
1,363 (+9.82%) |
Filing History |
| 2021-08-27 5:02 pm Purchase |
2021-08-17 | 13D | Dermata Therapeutics, Inc. DRMA |
HALE DAVID F | 2,597 7.500% |
2,597 (New Position) |
Filing History |
| 2021-08-27 5:00 pm Purchase |
2021-08-17 | 13D | Dermata Therapeutics, Inc. DRMA |
PROEHL GERALD T | 13,880 39.200% |
13,880 (New Position) |
Filing History |